FDA Inspection
Robert C. Stoler, M.D.Robert C. Stoler, M.D. – FDA Inspection, Jul 25, 2011
Record Details
This FDA Inspection record concerns Robert C. Stoler, M.D., with an inspection on July 25, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Robert C. Stoler, M.D.
- Inspection Date
- July 25, 2011
- Product Type
- Drugs
View Company Profile
ID · 9e8a2ea7-3e17-4e4a-b012-2e26951d393e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 735694
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Robert C. Stoler, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 2, 2020 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| August 11, 2016 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Robert C. Stoler, M.D.
- FDA Inspection 1121106 - 2020-03-02
- FDA Inspection 985147 - 2016-08-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.